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Abstract Sea urchin fibropellins are epidermal growth factor
homologues that harbor a C-terminal domain, similar in sequence
to hen egg-white avidin and bacterial streptavidin. The fibropellin
sequence was used as a conceptual template for mutation of
designated conserved tryptophan residues in the biotin-binding
sites of the tetrameric proteins, avidin and streptavidin. Three
different mutations of avidin, Trp-110-Lys, Trp-70-Arg and the
double mutant, were expressed in a baculovirus-infected insect
cell system. A mutant of streptavidin, Trp-120-Lys, was similarly
expressed. The homologous tryptophan to lysine (WCK)
mutations of avidin and streptavidin were both capable of
binding biotin and biotinylated material. Their affinity for the
vitamin was, however, significantly reduced: from KdV10315 M
of the wild-type tetramer down to KdV1038 M for both WCK
mutants. In fact, their binding to immobilized biotin matrices
could be reversed by the presence of free biotin. The Trp-70-Arg
mutant of avidin bound biotin very poorly and the double mutant
(which emulates the fibropellin domain) failed to bind biotin at
all. Using a gel filtration fast-protein liquid chromatography
assay, both WCK mutants were found to form stable dimers in
solution. These findings may indicate that mimicry in the nature
of the avidin sequence and fold by the fibropellins is not designed
to generate biotin-binding, but may serve to secure an appro-
priate structure for facilitating dimerization.
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1. Introduction
Chicken egg-white avidin and bacterial streptavidin share a
similar high a⁄nity for the vitamin biotin (KdV10315 M),
although their primary structures are not well-conserved
(V30% identity and 41% similarity) [1]. In spite of the rela-
tively low sequence homology, the two proteins share the
same tertiary fold, similar tetrameric quaternary structures
and a nearly identical arrangement of amino acids within their
respective biotin-binding pockets [1^4].
A family of other proteins exists, the ¢bropellins, which
harbor a C-terminal domain similar in sequence to avidin
and streptavidin [5,6]. Fibropellins are epidermal growth fac-
tor (EGF) homologues found in the hyaline layer of the ex-
tracellular matrix in sea urchin embryos. The ¢bropellins of
interest to our studies consist of repeated EGF-like N-termi-
nal domains and, unexpectedly, a single avidin-like C-terminal
domain. However, neither the function nor the three-dimen-
sional structure of the avidin-like domain is known. It is not
even known whether the domain is capable of binding biotin.
Comparison of the amino acid residues of the ¢bropellins,
which are homologous to the biotin-binding residues of avidin
and streptavidin, revealed that most of them appeared to be
conserved. The most remarkable alteration is the replacement
of Trp-110 in avidin (equivalent to Trp-120 in streptavidin)
with Lys in all four ¢bropellins [7].
In our previous studies on the structure-function relation-
ship in the avidin/streptavidin-biotin system, we have em-
ployed a variety of di¡erent approaches to examine how £ex-
ible one can be in modifying di¡erent amino acids in the
binding site while still conserving the property of biotin-bind-
ing. These include chemical modi¢cation studies [8^12], X-ray
analysis [1,13] and sequence comparisons with naturally oc-
curring, biotin-binding proteins, e.g. di¡erent types of strep-
tavidins [14] and avidin-related proteins [15]. The results in-
dicated that there is little compromise regarding the types and
positions of binding site residues. Most of them are strictly
conserved, in order to maintain the property of strong binding
to biotin. On the other hand, considerable £exibility can be
applied in modifying residues outside of the binding site. In
this regard, only about 30% of the primary structure is con-
served between avidin and streptavidin [1].
As structural and potentially functional entities, both the
avidin and streptavidin tetramer can conceivably be divided
into three di¡erent types of dimer pairs [1]. ‘Functional’
dimers would presumably be formed between monomers 1
and 2 and between monomers 3 and 4, numbered according
to Livnah et al. [1], wherein the conserved Trp-110 of one
avidin monomer (Trp-120 in streptavidin) is part of the bio-
tin-binding pocket of its a⁄liate and vice versa. ‘Structural’
dimers were likely formed between monomers 1 and 4 (or 2
and 3) in both proteins. Trp-110 (or Trp-120) is also note-
worthy in another sense: this particular residue has a remark-
able e¡ect on the stability of the tetrameric proteins [1].
In view of the natural ‘replacement’ of Trp-110 to Lys in
¢bropellin, it was of interest to determine how such a replace-
ment would a¡ect the characteristics of biotin-binding and the
quaternary structure of either avidin or streptavidin. Our ¢nd-
ings indicate that such a mutation results in a stable dimer in
both proteins, which exhibit reversible biotin-binding proper-
ties.
(Preliminary results of this work were presented at the 13th
Symposium of the Protein Society (July 1999, Boston, MA,
USA), Abstracts, 164-M, p. 84).
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2. Materials and methods
2.1. Materials
Biotin-agarose and 2-iminobiotin-agarose were purchased from Sig-
ma Chemical (St. Louis, MO, USA). Egg-white avidin was a gift of
Belovo Chemicals (Bastogne, Belgium) or STC (Winnipeg, Man.,
Canada). Nitro-avidin was prepared as previously described [16].
Streptavidin was provided by S.p.a. (Milan, Italy). Rabbit avidin
and streptavidin antibodies were acquired from DAKO A/S (Glos-
strup, Denmark). Goat anti-rabbit immunoglobulin G (IgG) alkaline
phosphate conjugate and the low-range sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) molecular weight stand-
ards were purchased from Bio-Rad Laboratories (Hercules, CA,
USA). JM109 and DH10Bac Escherichia coli strains were used in
cloning procedures. Mutants were produced in baculovirus-infected
Sf9 insect cells.
2.2. Recombinant bacmids and baculoviruses
Multiple sequence alignment (not shown) of avidin, streptavidin
and sea urchin ¢bropellins was carried out using CUSTAL X [17]
and the GCG package (Genetic Computer Group, Madison, WI,
USA) was employed to calculate the theoretical molecular weights
for the mutant proteins.
Avidin and streptavidin cDNAs were mutated by the megaprimer
method [18], using pGEMAV as an avidin template [19] and the
streptavidin gene from S. avidinii, prepared as previously described
[20]. After a second PCR ampli¢cation, the product for the avidin
mutant was digested with BglII and HindIII and the product for the
streptavidin mutant was digested with BamHI and HindIII. Both di-
gests were then extracted from agarose and cloned into BamHI/Hin-
dIII-treated pFASTBAC1 to construct the recombinant vectors, pFN9
(avidin mutant Avm-W110K), pFN10 (Avm-W70R), pFN17 (Avm-
W70R and W110K) and pFSAK (streptavidin mutant Savm-
W120K). The resultant vectors were transformed into JM109 cells
to construct the recombinant baculoviruses. The correct nucleotide
sequence was con¢rmed in each case by dideoxynucleotide sequencing
with an automated DNA sequencer. The preparations of the recombi-
nant viruses were ¢nally completed according to the manufacturer’s
instructions for the Bac-To-Bac Baculovirus Expression System (Gib-
co BRL, Life Technologies, Gaithersburg, MD, USA).
The primary virus stocks were ampli¢ed for large-scale production
of the mutants (Avm-W110K, Avm-W70R, Avm-W70R and Savm-
W120K) and the titers of virus stocks were determined by a plaque
assay procedure [21].
2.3. Preparation of mutant proteins
Production of mutant proteins was carried out essentially as pre-
viously described for recombinant avidin [22], with the exception that
the cell density in di¡erent experiments varied from 1U106/ml to
2U106/ml and the m.o.i. from 0.1 to 5. In experiments where mutant
proteins were puri¢ed, infections were carried out with cells that were
transferred to biotin-free medium (Gibco BRL, Cat. # 041-94100).
Puri¢cation of the mutant proteins from the corresponding cell
extract was performed on 2-iminobiotin-agarose as reported by Air-
enne et al. [22]. Following cell lysis, the soluble fraction was brought
to pH 11 and applied to a 2-iminobiotin-agarose column. The mu-
tants were eluted using 50 mM ammonium acetate (pH 4/0.1 M
NaCl). Later in the study, puri¢cation of Avm-W110K on a biotin-
agarose column proved superior to that using 2-iminobiotin. In this
case, the pH of the cell extract was not altered prior to application on
the column. Adsorbed material was eluted either using 0.2 mg/ml
biotin in 50 mM ammonium acetate (pH 4/0.1 M NaCl) or by 0.4
M acetic acid.
2.4. Biotin-binding assays
Biotin-binding was initially assessed by a dot blot assay, using a
modi¢cation of procedures described in Bayer et al. [23] and Bayer
and Wilchek [24]. Brie£y, successive dilutions of biotinylated bovine
serum albumin (BSA) were applied to dot blots. The blots were
quenched using BSA and an avidin, streptavidin or mutant test sam-
ple (1 Wl of a 20 Wg/ml solution in phosphate-bu¡ered saline (PBS))
was applied. The interaction was carried out at 23‡C for 30 min. The
blots were washed with PBS-0.5% (v/v) Tween solution and stained
immunochemically as described below.
A complementary method was used to achieve de¢ned a⁄nity con-
stants for the mutants. An IASyS optical biosensor (A⁄nity Sensors,
Cambridge, UK) and commercially available biotin-aminosilane cu-
vette (FCB5401) were used to obtain the kinetic measurements of the
interaction between Avm-W110K or Savm-W120K and biotin. Di¡er-
ent concentrations of mutant protein were allowed to bind to the
biotinylated surface and the a⁄nity constants were calculated using
the FAST¢t software, developed by A⁄nity Sensors. Experiments
were performed in PBS, containing 1 M NaCl, and cuvette regener-
ation was accomplished by 20 mM HCl.
2.5. Reversibility assays
2.5.1. Competitive biotin-binding enzyme-linked immunosorbent
assay (ELISA). Microtiter plates were coated with 1 Wg biotinylated
BSA per well in 100 Wl coating bu¡er (15 mM sodium carbonate
bu¡er, pH 9.6). The plates were incubated overnight at 4‡C (or, alter-
natively, at 37‡C for 2 h), washed with PBS, quenched using 0.5%
BSA in PBS at 37‡C for 1 h and washed again in wash bu¡er A (1 M
NaCl and 0.5% v/v Tween 20 in PBS). Three concentrations (10,
20 and 50 ng/well in assay bu¡er A, consisting of 0.5% BSA, 0.5%
Tween 20 and 1 M NaCl in PBS) of mutant were applied in sextupli-
cate to the wells. Native avidin was used as a negative control (i.e. no
reversibility) and nitro-avidin [16] as a positive control (normally
V70% reversibility). The wells were washed with wash bu¡er A.
At this point, the microtiter plate contained di¡erent types of avidin
or streptavidin or mutant, bound through the biotin moiety of the
adsorbed biotinylated BSA. The remainder of the assay was designed
to test how much could be released using biotin.
Half of the appropriate wells (i.e. three wells each of the test sam-
ples) was incubated with 0.5 mM biotin dissolved in assay bu¡er A at
37‡C for 1 h, in an attempt to displace, if possible, the adsorbed
protein from the biotinylated BSA. The plates were then washed three
times with wash bu¡er A and once with PBS alone.
The amounts of avidin, streptavidin, nitro-avidin or mutant remain-
ing on the plates was determined immunochemically as described
below. The percentage reversibility of the interaction between the
desired biotin-binding protein and the biotin ligand was determined
according to the following equation:
Reversibility %  100A3B=A
where A = the amount of protein bound to the wells in the initial
interaction and B = the amount of protein remaining after subsequent
interaction with free biotin.
2.5.2. Competitive biosensor technology. A complementary reversi-
bility assay was also devised, which employed the optical biosensor
(IASyS) and commercial biotin cuvettes as described above. In this
case, avidin, streptavidin or their mutants were allowed to bind to the
biotin-aminosilane cuvette in PBS, containing 1 M NaCl. After care-
ful washing, the binding was measured and the binding bu¡er was
saturated with biotin. The proteins were allowed to elute until the
system reached an equilibrium level. After this, another extended
wash was performed using the binding bu¡er. The residual amounts
of bound protein, following the wash, were compared to those meas-
ured after the initial binding phase and reversibility was determined
according to the above equation.
2.6. Immunoassay
Avidin- or streptavidin-containing dot blots or plates were incu-
bated with rabbit anti-avidin or anti-streptavidin Ig at 37‡C for 1 h.
The antibody was diluted (1:5000 from a 10 mg/ml solution) in assay
bu¡er B (0.5% BSA, 0.05% v/v Tween 20, 0.9% NaCl and 0.05% w/v
sodium azide in 50 mM Tris-HCl bu¡er, pH 7.75) to prepare ¢nal
concentrations of 3 Wg/ml for nitrocellulose strips and 330 ng/well for
microtiter plates. The plates were again washed three times with wash
bu¡er B (0.05% v/v Tween 20 in 50 mM Tris-HCl bu¡er, pH 7.75)
and then incubated with anti-rabbit IgG-conjugated alkaline phospha-
tase (Jackson ImmunoResearch) at 37‡C for 1 h, diluted 1:5000 in
assay bu¡er B. Following another three washes in wash bu¡er B and a
single wash in PBS, substrate solution (10 mg p-nitrophenyl phos-
phate in 10 ml 0.1 M diethanolamine bu¡er, pH 9.8, containing
0.5 mM MgCl2) was added. Color development (405 nm) was meas-
ured at 15 min intervals, using an EL309 Microplate Autoreader (Bio-
Tek Instruments, Burlington, VT, USA).
2.7. Sensitivity to proteases
A sample (50 Wl of a 1 mg/ml aqueous solution of avidin, strepta-
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vidin or mutant in the presence or absence of excess free biotin) was
added to an equal volume of 100 mM Tris-HCl bu¡er, pH 7.8. To this
solution, proteinase K (5 Wl of a 0.2 mg/ml aqueous solution) was
added. The reaction solution was incubated at 37‡C. At designated
time intervals, 20 Wl samples were taken and stored at 320‡C. To each
sample, 10 Wl of sample bu¡er was added, the samples were boiled
and subjected to SDS-PAGE on 18% gels. The amount of intact
avidin in the expected band was determined in each sample by densi-
tometry and compared to that of an untreated control sample (de¢ned
as 100%). The results were graphed as stability to protease treatment
(sample/controlU100%) versus time of reaction.
2.8. Miscellaneous methods
SDS-PAGE and immunoblot analyses were as previously reported
by Airenne et al. [22]. For thermostability analysis, the protein sam-
ples were combined with sample bu¡er and incubated at selected
temperatures for 20 min before being subjected to SDS-PAGE [24]
on 15% gels. The gels were stained using Coomassie brilliant blue.
Circular dichroism (CD) spectroscopy studies were carried out us-
ing a Jasco 715 circular dichrometer at the far-UV region. Measure-
ments were performed in circular 1 mm cuvettes at 22‡C in 100 mM
potassium phosphate bu¡er, pH 7.4. Variance, caused by di¡erent
concentrations, was corrected in ¢nal spectra.
The quaternary status of avidin, streptavidin or mutants was deter-
mined by fast-protein liquid chromatography (FPLC), performed on a
Superose-12 column (Pharmacia) using a LKB HPLC system. Sam-
ples (40 Wg in 100 Wl phosphate bu¡er in 0.65 M NaCl, pH 7.2) were
applied and chromatography was carried out at a £ow rate of 0.5 ml/
min, using the same bu¡er and ionic strength in the equilibration and
running phases. The column was calibrated using bovine Q-globulin,
BSA, an egg-white avidin standard, ovalbumin, carbonic anhydrase,
ribonuclease and cytochrome c as molecular weight markers.
3. Results
3.1. Synthesis and puri¢cation of mutant proteins
Sf9 cells, infected with recombinant viruses, produced three
separate protein bands in SDS-PAGE, which were detected by
immunoblot analysis using avidin-speci¢c antibody. The
bands represent carbohydrate-free and two di¡erently glyco-
sylated avidin forms [22]. These bands were not observed from
cells infected by wild-type virus (not shown). Cell lysates were
clari¢ed by centrifugation (1000Ug, room temperature, 5 min)
and adjusted to pH 11/1 M NaCl before being subjected to
puri¢cation on 2-iminobiotin-agarose. The e⁄ciency of such
columns was less than 25% for Avm-W110K. The residual
fraction was therefore subjected to puri¢cation using a bio-
tin-agarose column and the ¢nal combined yield surpassed
75%. The same high yield could also be achieved by purifying
mutant samples with biotin-agarose alone. E⁄cient elution of
the 2-iminobiotin-puri¢ed Avm-W110K was achieved using
pH 4 bu¡er. A biotin-containing solution was e¡ective for
elution of the mutant protein from biotin-agarose. Elution
using 0.4 M acetic acid was also possible but less e⁄cient.
Savm-W120K was prepared by a similar procedure. Fol-
lowing SDS-PAGE and immunoblot analysis, only a single
band, consistent with monomeric core streptavidin, was de-
tected by streptavidin-speci¢c antibody. The mutant protein
was isolated on a 2-iminobiotin column and e⁄cient elution
of Savm-W120K was achieved using pH 4 bu¡er.
In contrast to successful puri¢cation of Avm-W110K and
Savm-W120K, we were unable to purify two other avidin
mutants, Avm-W70R and Avm-W70R and W110K, using
2-iminobiotin or biotin columns.
3.2. Biotin-binding properties
Dot blot assays revealed that both the puri¢ed Avm-
W110K and Savm-W120K mutants bound biotin (not
shown). In order to provide more quantitative data, the
WCK mutants were subjected to interaction analysis using
an IASyS apparatus and a biotin-aminosilane cuvette. Using
this system, a measurable dissociation constant (Kd value) for
the interaction between Avm-W110K and biotin was deter-
mined directly from the binding curves to be 2.8U1038 M
(Table 1). A very similar value (2.7U1038 M) was also ob-
tained from the equilibrium response data. The equivalent
values for Savm-W120K were 5.8 and 5.9U1038 M. Unlike
biotin cuvettes adsorbed with native avidin, the mutant-ad-
sorbed cuvettes could be regenerated completely by a 1 min
wash with 20 mM HCl.
As shown in Fig. 1, the biotin-binding property of both
WCK mutants was reversible. In fact, the extent of release
of the mutant from the biotinylated surface was superior to
that exhibited by nitro-avidin [16]. The results for reversibility
of binding were similar for both of the assay techniques used
in this study.
3.3. Structural and stability properties of Avm-W110K and
Savm-W120K
The secondary structure of Avm-W110K was studied by
Table 1
A⁄nity constants between immobilized biotin and the mutants, determined using an IASyS optical biosensor
Mutant kass (M31 s31) kdiss (s31) Kd (M)a Kd (M)b
Avm-W110K 1.08U106 0.0292 2.7U1038 2.8U1038
Savm-W120K 0.118U106 0.0071 6.0U1038 5.8U1038
aThe dissociation constant (Kd) was calculated from the kass (association rate constant), derived from association analysis using the plot of Kon
against the protein concentration, and the kdiss (dissociation rate constant), calculated directly from dissociation curves.
bThe dissociation constant was determined directly from the binding curves.
Fig. 1. Reversibility of biotin-binding activity of the WCK mutants
of avidin and streptavidin. Both ELISA and IASyS protocols were
used (see Section 2) and the results are expressed as % reversibility
(mean þ S.E.M.). Avidin and streptavidin were used as negative
(irreversible) controls and nitro-avidin was used as a positive con-
trol.
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CD spectroscopy. The far-UV spectra (data not shown) re-
sembled that of the wild-type avidin [25], suggesting that the
L-barrel fold of the avidin mutant had remained intact.
In order to determine the quaternary status of the WCK
mutants, gel ¢ltration FPLC was performed (Fig. 2). In each
case, the mutant migrated as a single symmetrical peak (Fig.
2, inset). When compared to standards and a commercial
avidin preparation, the molecular weight of the Avm-
W110K mutant was determined to be 31 200 Da (average of
three independent experiments). The calculated theoretical
molecular weight of the monomer (without sugar) is 14 285
Da and the carbohydrate moiety comprises about 10% of the
molecular mass [26,27]. According to these values, the best ¢t
for the quaternary state of Avm-W110K is a dimer, the hypo-
thetical molecular weight of which would be approximately
31 500 Da. The corresponding streptavidin mutant, Savm-
W120K, gave a similar value of 36 700 Da, which is also
consistent with a dimer. The presence of biotin failed to a¡ect
the apparent quaternary structures of either mutant. Both
Avm-W110K and Savm-W120K behaved as dimers whether
in the presence or in the absence of biotin. Thus, in each case,
mutation of Trp-110 in avidin or the analogous residue (Trp-
120) in streptavidin caused a conversion of the tetramer to a
dimeric form of the mutant protein.
SDS-PAGE has previously been used to analyze the stabil-
ity properties of avidin, streptavidin [22,28] and a progressive
series of avidin charge mutants [29]. Using this procedure,
both Avm-W110K and Savm-W120K were found to dissoci-
ate into monomers in the presence of SDS already at room
temperature (Fig. 3). Unlike the native proteins and reduced
charge mutants, the presence of biotin failed to stabilize the
WCK mutants and tetramers were not observed. These re-
sults are consistent with the FPLC data, which demonstrated
the dimeric nature of both mutant proteins. In both cases, the
respective dimer is less stable than the native tetramer and the
detergent appears to convert the dimer to the monomer.
The stability properties of both mutants were also studied
by their susceptibility to proteinase K treatment. Compared to
native avidin, Avm-W110K was extremely sensitive to pro-
tease treatment (Fig. 4). Within minutes, all of the avidin
dimer was cleaved and the resultant lower-molecular weight
bands were consistent with the previously described proteinase
K-sensitive cleavage site in one of the loops [30]. Unlike native
avidin, the presence of biotin failed to protect the mutant
from rapid proteolytic cleavage. In contrast, the streptavidin
mutant Savm-W120K, like the native protein, was completely
stable to the action of proteinase K, both in the presence and
in the absence of biotin.
Both WCK mutants of avidin and streptavidin were gen-
erally quite stable under normal conditions. One indication of
such a stability of the Avm-W110K mutant is the observation
that a sample, stored at room temperature in the absence of
preservatives for 1 month, was unaltered in its biotin-binding
properties, as measured by optical biosensor analysis (IASyS)
as described above (not shown).
4. Discussion
The impetus and rationale behind this work emanates from
the comparison of three di¡erent protein families, egg-white
avidin, bacterial streptavidin and sea urchin ¢bropellin, which
are moderately conserved in their primary amino acid sequen-
ces [6]. Two of these proteins, avidin and streptavidin, bind
the vitamin biotin with the highest known biological interac-
Fig. 2. FPLC gel ¢ltration pro¢le of the WCK mutants of avidin
and streptavidin, in the presence and absence of free biotin. A com-
mercial Superose-12 column was used for separation. Human Ig
(IgG), BSA, avidin (Av), ovalbumin (Ov) and cytochrome c (Cyt c)
were used as markers to calibrate the column. The inset shows the
observed peak for Avm-W110K. Very similar, well-de¢ned peaks
were also obtained for Savm-W120K and for both mutants in the
presence of biotin. The migration pattern of both mutants is consis-
tent with a dimer, whether in the absence or presence of biotin.
Fig. 3. Thermostability analysis of avidin, streptavidin and their
WCK mutants in the presence of SDS. Samples in the presence or
absence of free biotin were dissolved in SDS-containing sample bu¡-
er, incubated for 20 min at the indicated temperatures and subjected
to SDS-PAGE. The ratio of tetramer to monomer was determined
by densitometry tracings and the results were graphed as a function
of the temperature [26].
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tion between a protein and a small ligand [31]. Their three-
dimensional structures have been determined and the residues
of the protein which interact with biotin have been character-
ized [1^4]. In contrast, the structure and function of the avi-
din-like domain of the ¢bropellins are unknown and a re-
combinant form has yet to be expressed. Despite the
striking resemblance of its primary structure to both avidin
and streptavidin, it is not yet known whether ¢bropellins bind
to biotin or not.
Most of the important biotin-binding residues in avidin and
streptavidin are conserved in the ¢bropellins (Table 2). Several
discrepancies, however, can be noted. For example, a binding
site serine residue in both avidin and streptavidin, which
forms a hydrogen bond with the carbonyl carbon of the biotin
ureido ring [1^4], is substituted in the ¢bropellins by an as-
partic acid. Aspartic acid, however, is also capable of forming
a hydrogen bond and one could envision a conservative sub-
stitution in this case. Much more intriguing is the replacement
of two tryptophans, which contribute to the aromatic cage of
the binding pocket. One of these is replaced by an arginine
and a second by a lysine. Using this information, we tried to
replace either or both of these tryptophan residues in avidin to
see whether the mutant proteins could be expressed in a func-
tional form. Thus far, we were able to express all three mu-
tants, i.e. Avm-W110K, Avm-W70R and the double mutant
Avm-W70R and W110K. The latter, however, appeared to be
inactive and failed to bind to either 2-iminobiotin-agarose or
biotin-agarose. The Avm-W70R mutant appeared to exhibit
relatively low binding to both columns, but we were as yet
unable to prepare su⁄cient protein for biochemical analysis.
Therefore, the present article concentrates on our successful
cloning and expression of Avm-W110K. On the basis of the
results obtained for this mutant, we also prepared and exam-
ined the cognate mutant from streptavidin, namely Savm-
W120K.
It is perhaps fortunate that we had nature on our side to
guide us in the choice of these two related mutations, since the
replacement of a tryptophan by a lysine is clearly an unortho-
dox substitution. It is interesting that such an extraordinary
mutation did not seem to interfere signi¢cantly with the ex-
pression and puri¢cation of the mutant proteins, a fact that
probably re£ects the remarkable stability of the native pro-
tein. Nevertheless, the WCK mutation had two major e¡ects
on the avidin and streptavidin molecules. In both proteins,
stable dimers were generated and the a⁄nity constant for
biotin was signi¢cantly reduced. In fact, the interaction of
Avm-W110K and Savm-W120K with biotin was essentially
reversible.
In retrospect, it is not particularly surprising that the
WCK mutation resulted in the production of a dimeric
form of avidin and streptavidin. In both native proteins, the
respective tryptophan is contributed to the binding site of one
monomer by an extended pair of L-strands from its symmetry-
related neighbor, thus comprising a major component of the
‘functional’ 1C2 (and 3C4) interface of the tetramer [1^4].
Nevertheless, in order to form a dimer from a tetramer, two
di¡erent interfaces must be impaired, the inference being that
both the 1C2 and the relatively weak 1C3 interfaces would
be a¡ected by the single, dramatic mutation of tryptophan
(110 in avidin and 120 in streptavidin) to lysine. This would
result in the formation of stable ‘structural’ dimers, in which
the extensive network of hydrogen-bonding interactions along
the 1C4 (and 2C3) interface would presumably be retained.
However, this network of hydrogen bonds was sensitive to
SDS and its presence caused the dissociation of the dimer
into the monomer even at room temperature.
Regarding the observed protease-sensitivity of the avidin
mutant, Ellison et al. [30] proposed that the mechanism of
biotin-induced protection of native avidin against proteinase
K treatment is related to the known closure and rigidi¢cation
of the sensitive loop between L-strands 3 and 4. In Avm-
W110K, biotin failed to protect the mutant against proteolytic
attack, thus suggesting that the tertiary structure of the mu-
Fig. 4. Sensitivity of the WCK mutants of avidin and streptavidin
to proteolytic digestion by proteinase K. The mutants or native pro-
teins, in the presence or absence of biotin, were mixed with a 1:50
ratio (w/w) of proteinase K to target protein and samples were tak-
en at the designated time intervals. The samples were dissolved in
SDS-containing sample bu¡er, boiled for 10 min and subjected to
SDS-PAGE. The values represent the relative percentage of intact
monomer observed in the sample, graphed as a function of time.
Table 2
Conserved binding site residues in avidin and streptavidin and their
analogues in sea urchin ¢bropellins
Avidin Streptavidin Sea urchin ¢bropellina
N12 N23 N947
S16 S27 D951b
Y33 Y43 Y967
T35 S45 T969
W70 W79 R1002
T77 T90 T1009
F79 W97 W1011
W97 W108 W1028
W110 W120 K1041
N118 D128 D1049
aFibropellin residues were numbered according to GenBank acces-
sion number L08692. Analogous residues in the other three ¢bropel-
lins (L07045, L33861 and L33862) are identical, except that the resi-
due corresponding to tyrosine 33 in avidin is histidine in clones
L33862 and L07045.
bUnconserved residues in ¢bropellin are underlined.
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tant is altered such that the loop is more accessible to pro-
teolysis.
Mutations of W120 in streptavidin have been described
previously. In one study [32], the conservative mutation of
this residue to phenylalanine resulted in a reduction of the
binding constant for 2-iminobiotin by two orders of magni-
tude. Its replacement by alanine caused a more severe drop in
the a⁄nity of the mutated protein for biotin itself, to a meas-
urable value (1.1U1037 M), reminiscent of the dissociation
constant estimated for immobilized monomeric avidin
(Kd = 1037 M) [33,34]. Both of these streptavidin W120 mu-
tants were reported to assemble into tetramers.
In a more recent work, Sano et al. [35] described the con-
struction of a mutated form of streptavidin. In this work,
histidine 127 was changed to aspartic acid, in order to intro-
duce repulsive forces between subunits 1 and 2 (3 and 4). In
addition, the entire 8 residue loop, connecting L-strands 7 and
8, was deleted. W120 was among the residues contained in the
deleted loop. The resultant protein was shown to form a
soluble dimer in the presence of biotin. The authors assumed
that dimeric streptavidin would not be soluble because of the
high hydrophobicity of the loop. Since the entire loop was
deleted, it is not clear what consequences this would have
on the £anking residues that normally form the two separate
L-strands in question. Presumably, the residues immediately
adjacent to the deleted loop would rearrange into an alternate
loop, hence detracting from the lengths of one or both
strands. In any case, the authors observed that the stability
of the deletion mutant in dimeric form was contingent upon
the presence of biotin, the absence of which resulted in the
gradual dissociation into inactive monomers.
In contrast, the analogous WCK mutations, described in
this communication, were found to be both dimeric and solu-
ble. They also bind biotin reversibly and are stable under
long-term storage conditions, even in the absence of biotin.
These combined properties may therefore be useful for appli-
cation in puri¢cation studies, in which the recovery of bio-
tinylated proteins or other substances is desired.
Finally, it is intriguing to consider the results of this study
in light of the observations that led to the design of the mu-
tants. Speci¢cally, why would sea urchin ¢bropellins acquire
sequences from avidin (or streptavidin)? On the basis of the
present study, it would seem that the biotin-binding require-
ment may not have been the reason, since if high a⁄nity for
biotin was needed, then, one would have expected all of the
binding residues to have been retained. Indeed, the modi¢ca-
tion of one of the two homologous tryptophans (W110K and
W70R in avidin) caused a signi¢cant drop in a⁄nity. Mod-
i¢cation of both led to an inactive binding protein.
On the other hand, the stimulus for emulation of the avidin
sequence and fold by ¢bropellins may have been to secure an
appropriate structure for facilitating dimerization. In this con-
text, sea urchin ¢bropellins are extracellular matrix proteins,
which may be involved in cell-cell or cell-substratum interac-
tions during embryonic development [7]. The role of the avi-
din-like domain may be to form dimers and thereby promote
protein-protein interactions required for signal transduction.
Our results suggest that avidin could serve as an appealing
template for such processes, since the dimer a¡orded by the
W110K mutation is a stable one which exhibits a multiplicity
of hydrogen bonds across the relevant 1C4 interface. Never-
theless, hydrogen bonds are relatively easier to dissociate than
other kinds of bonds, as demonstrated for the W110K mutant
dimer, which reverts to the monomer in the presence of SDS.
In any case, the exact nature of interaction among ¢bropellin
components, including residual biotin-binding activity, would
be dependent on the microenvironment and structure of the
native protein. Further evidence in this direction awaits the
cloning, expression and analysis of ¢bropellin components.
Preliminary experiments in our laboratory (unpublished re-
sults) have indicated that an expressed avidin-like domain of
a ¢bropellin failed to bind to immobilized biotin-containing
matrices.
Acknowledgements: The authors thank Mrs. Irene Helkala and Anne
Ettala, Ms. Satu Pekkala and Mr. Henri Nordlund for ¢rst class
technical assistance. We also thank Prof. Matti Vuento for CD spec-
troscopy analysis of native and mutated avidin. The study was sup-
ported by Grants from the Academy of Finland (SA 29783) and the
Israel Science Foundation (administered by the Israel Academy of
Sciences and Humanities, Jerusalem, Israel).
References
[1] Livnah, O., Bayer, E.A., Wilchek, M. and Sussman, J.L. (1993)
Proc. Natl. Acad. Sci. USA 90, 5076^5080.
[2] Hendrickson, W.A., Pa«hler, A., Smith, J.L., Satow, Y., Merritt,
E.A. and Phizackerley, R.P. (1989) Proc. Natl. Acad. Sci. USA
86, 2190^2194.
[3] Weber, P.C., Ohlendorf, D.H., Wendoloski, J.J. and Salemme,
F.R. (1989) Science 243, 85^88.
[4] Pugliese, L., Coda, A., Malcovati, M. and Bolognesi, M. (1993)
J. Mol. Biol. 231, 698^710.
[5] Bisgrove, B.W., Andrews, M.E. and Ra¡, R.A. (1991) Dev. Biol.
146, 89^99.
[6] Hunt, L.T. and Barker, W.C. (1989) FASEB J. 3, 1760^1764.
[7] Bisgrove, B.W., Andrews, M.E. and Ra¡, R.A. (1995) J. Mol.
Evol. 41, 34^45.
[8] Gitlin, G., Bayer, E.A. and Wilchek, M. (1987) Biochem. J. 242,
923^926.
[9] Gitlin, G., Bayer, E.A. and Wilchek, M. (1988) Biochem. J. 256,
279^282.
[10] Gitlin, G., Bayer, E.A. and Wilchek, M. (1988) Biochem. J. 250,
291^294.
[11] Gitlin, G., Khait, I., Bayer, E.A., Wilchek, M. and Muszkat,
K.A. (1989) Biochem. J. 259, 493^498.
[12] Gitlin, G., Bayer, E.A. and Wilchek, M. (1990) Biochem. J. 269,
527^530.
[13] Livnah, O., Bayer, E.A., Wilchek, M. and Sussman, J.L. (1993)
FEBS Lett. 328, 165^168.
[14] Bayer, E.A., Kulik, T., Adar, R. and Wilchek, M. (1995) Bio-
chim. Biophys. Acta 1263, 60^66.
[15] Keina«nen, R., Walle¤n, M., Kristo, P., Laukkanen, M., Toimela,
T., Helenius, M. and Kulomaa, M. (1994) Eur. J. Biochem. 220,
615^621.
[16] Morag, E., Bayer, E.A. and Wilchek, M. (1996) Biochem. J. 316,
193^199.
[17] Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F. and
Higgins, D.G. (1997) Nucleic Acids Res. 25, 4876^4882.
[18] Sarkar, G. and Sommer, S.S. (1990) BioTechniques 8, 404^407.
[19] Airenne, K.J., Sarkkinen, P., Punnonen, E.-L. and Kulomaa,
M.S. (1994) Gene 144, 75^80.
[20] Argaran‹a, C.E., Kuntz, I.D., Birken, S., Axel, R. and Cantor,
C.R. (1986) Nucleic Acids Res. 14, 1871^1882.
[21] O’Reilly, D.R., Miller, L.K. and Luckov, V.A. (1994) Oxford
University Press, New York.
[22] Airenne, K.J., Oker-Blom, C., Marjoma«ki, V.S., Bayer, E.A.,
Wilchek, M. and Kulomaa, M.S. (1997) Protein Expr. Purif. 9,
100^108.
[23] Bayer, E.A., Ben-Hur, H. and Wilchek, M. (1988) Anal. Bio-
chem. 170, 271^281.
[24] Bayer, E.A. and Wilchek, M. (1996) in: Immunoassay (Diaman-
dis, E.P. and Christopoulos, T.K., Eds.), pp. 237^267, Academic
Press, San Diego, CA.
FEBS 22858 4-11-99
O.H. Laitinen et al./FEBS Letters 461 (1999) 52^58 57
[25] Green, N.M. and Melamed, M.D. (1966) Biochem. J. 100, 614^
621.
[26] Green, N.M. (1975) Adv. Protein Chem. 29, 85^133.
[27] Hiller, Y., Gershoni, J.M., Bayer, E.A. and Wilchek, M. (1987)
Biochem. J. 248, 167^171.
[28] Bayer, E.A., Ehrlich-Rogozinski, S. and Wilchek, M. (1996) Elec-
trophoresis 17, 1319^1324.
[29] Marttila, A.T., Airenne, K.J., Laitinen, O.H., Bayer, E.A., Wil-
chek, M. and Kulomaa, M.S. (1998) FEBS Lett. 441, 313^317.
[30] Ellison, D., Hinton, J., Hubbard, S.J. and Beynon, R.J. (1995)
Protein Sci. 7, 1337^1345.
[31] Green, N.M. (1990) Methods Enzymol. 184, 51^67.
[32] Chilkoti, A., Tan, P.H. and Stayton, P.S. (1995) Proc. Natl.
Acad. Sci. USA 92, 1754^1758.
[33] Green, N.M. and Toms, E.J. (1973) Biochem. J. 133, 687^700.
[34] Kohanski, R.A. and Lane, M.D. (1990) Methods Enzymol. 184,
194^200.
[35] Sano, T., Vajda, S., Smith, C. and Cantor, C. (1997) Proc. Natl.
Acad. Sci. USA 94, 6153^6158.
FEBS 22858 4-11-99
O.H. Laitinen et al./FEBS Letters 461 (1999) 52^5858
